These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18549004)

  • 41. The hidden costs of free lunches: fraud and abuse in physician-pharmaceutical arrangements.
    Gosfield AG
    J Med Pract Manage; 2005; 20(5):253-8. PubMed ID: 15921138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Is drug promotion ethical in Peru?].
    Florián Castro R
    Gac Sanit; 2016; 30(2):159. PubMed ID: 26680685
    [No Abstract]   [Full Text] [Related]  

  • 43. Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry.
    Hagen B; Pijl-Zieber EM; Souveny K; Lacroix A
    Can Nurse; 2008 Apr; 104(4):30-5. PubMed ID: 18488765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Industry relationships with physicians under scrutiny.
    Beller GA
    J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446
    [No Abstract]   [Full Text] [Related]  

  • 46. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine.
    Rubin EB; Bernat JL
    Headache; 2008; 48(10):1545-9. PubMed ID: 19076654
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug reps and the academic medical center: a case for management rather than prohibition.
    Huddle TS
    Perspect Biol Med; 2008; 51(2):251-60. PubMed ID: 18453729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medicine and the pharmaceutical industry: a call to action.
    Stiles MM; Barrett B
    Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
    [No Abstract]   [Full Text] [Related]  

  • 49. Professionalism and physician interactions with industry.
    Collins J
    J Am Coll Radiol; 2006 May; 3(5):325-32. PubMed ID: 17412075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attitudes of physicians and public to pharmaceutical industry 'gifts'.
    Macneill PU; Kerridge IH; Newby D; Stokes BJ; Doran E; Henry DA
    Intern Med J; 2010 May; 40(5):335-41. PubMed ID: 20345507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Sunshine Act: how to avoid getting burned.
    Hurd P
    Fam Pract Manag; 2013; 20(5):8-10. PubMed ID: 24134101
    [No Abstract]   [Full Text] [Related]  

  • 52. Industry support of graduate medical education in surgery.
    Nakayama DK; Bozeman AP
    Am Surg; 2009 May; 75(5):395-400. PubMed ID: 19445290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A quiz on "the ethics of accepting gifts from industry".
    Holm RP;
    S D Med; 2007 Mar; 60(3):117-8. PubMed ID: 17455581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Collaborations between surgeons and industry are productive and beneficial to patients.
    Nakayama D
    J Am Coll Surg; 2010 Jul; 211(1):146-7; author reply 147. PubMed ID: 20610270
    [No Abstract]   [Full Text] [Related]  

  • 55. Charities and patient groups should declare interests.
    Hirst J
    BMJ; 2003 May; 326(7400):1211. PubMed ID: 12775630
    [No Abstract]   [Full Text] [Related]  

  • 56. Don't forget other medical suppliers.
    Summers D
    BMJ; 2011 Nov; 343():d7027. PubMed ID: 22046014
    [No Abstract]   [Full Text] [Related]  

  • 57. Conflicts of interest--an ever present challenge.
    Kopp I
    Dtsch Arztebl Int; 2013 Sep; 110(35-36):573-4. PubMed ID: 24078836
    [No Abstract]   [Full Text] [Related]  

  • 58. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
    Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
    Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Routine conflict of interest disclosure by preclinical lecturers and medical students' attitudes toward the pharmaceutical and device industries.
    Kim A; Mumm LA; Korenstein D
    JAMA; 2012 Dec; 308(21):2187-9. PubMed ID: 23212492
    [No Abstract]   [Full Text] [Related]  

  • 60. Curbing the influence of the drug industry: a British view.
    Smith R
    PLoS Med; 2005 Sep; 2(9):e241. PubMed ID: 16076242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.